Syncom Formulations (India) Limited (SYNCOMF.NS) NSE

Currency In INR

AD

Syncom Formulations (India) Limited

Address

207, Saket Nagar

Indore, MP 452018

India

Phone

91 73 1256 0458

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

998

First IPO Date

November 18, 2022

Key Executives

NameTitlePayYear Born
Vijay Shankarlal BankdaMD and Executive & Non Independent Director6.49M1958
Kedarmal Shankarlal BankdaWhole Time Director11.78M1952
Ankit Kedarmal BankdaExecutive Chairman01986
Vaishali AgrawalCompany Secretary & Compliance Officer0N/A
Ankur Vijay BankdaPresident of Export Marketing01985
Rakesh Chandra SrivastavaChief Marketing Officer01962
Payal Ankur BankdaVice President of Human Resources01987
Rahul Vijay BankdaChief Financial Officer & President of Domestic Marketing01980
AD

Description

Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.

AD